MedPath

Non-invasive Haemodynamic Monitoring in Pregnancy

Completed
Conditions
Cardiac Output, High
Pregnancy Related
Haemodynamic Instability
Registration Number
NCT03046784
Lead Sponsor
Hospital Nord
Brief Summary

This prospective and observational trial over 55 pregnant women (third trimester) compares non invasive haemodynamic monitoring using Nexfin technology and ultrasonography technic

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
55
Inclusion Criteria
  • third trimester of pregnancy
  • Non-labouring pregnant women
  • accepting study
Exclusion Criteria
  • refusal of study
  • first or second trimester of pregnancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cardiac output measure30 minutes

Cardiac output is measured with non-invasive digital Nexfin technology (ml/min) and compared with transthoracic echocardiographic measure of cardiac output (ml/min) used as reference.

Echographic cardiac output (ml/min) is measured as the produce of cross sectional aera of left ventricular outflow track (cm²) multiplied by velocity time index (cm) multiplied by heart rate (beat/min)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Departement anesthesie reanimation hopital nord

🇫🇷

Marseille, France

Departement anesthesie reanimation hopital nord
🇫🇷Marseille, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.